Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Microsoft
MSFT
5
Vale SA
VALE
US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 0.6541
- -0.0359-5.20%
Trading Apr 24 11:53 ET
21.71MMarket Cap-0.25P/E (TTM)
0.6660High0.5409Low3.39MVolume0.6194Open0.6900Pre Close2.08MTurnover11.10%Turnover RatioLossP/E (Static)33.19MShares4.470052wk High0.61P/B19.99MFloat Cap0.240452wk Low--Dividend TTM30.57MShs Float54.0000Historical High--Div YieldTTM18.13%Amplitude0.2404Historical Low0.6110Avg Price1Lot Size
Relmada Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -0.19%-51.76M | 14.15%-8.8M | -43.21%-16.66M | 0.08%-13.26M | 21.01%-13.04M | 50.23%-51.66M | 71.44%-10.25M | 56.70%-11.63M | 38.62%-13.27M | 15.05%-16.51M |
| Net income from continuing operations | 19.04%-79.98M | 25.86%-18.66M | 1.25%-21.73M | 29.78%-17.77M | 17.07%-21.83M | 37.09%-98.79M | 33.68%-25.17M | 44.18%-22M | 36.64%-25.3M | 33.78%-26.32M |
| Operating gains losses | -109.22%-374.93K | -101.22%-40.84K | -385.87%-147.84K | ---133.11K | -107.97%-53.13K | 594.15%4.06M | 9,932.59%3.35M | -90.79%51.71K | --0 | 4,338.21%666.71K |
| Change In working capital | -151.41%-1.58M | -46.50%2.9M | -49.18%-2.47M | -1,288.33%-2.62M | 165.65%599.76K | -70.92%3.08M | 252.02%5.43M | 54.69%-1.65M | -98.03%220.53K | -113.83%-913.58K |
| -Change in receivables | --0 | --0 | --0 | --0 | --0 | 220.27%512.43K | --0 | --0 | --0 | 2,349.13%512.43K |
| -Change in prepaid assets | -88.75%319.75K | -57.77%698.34K | -261.89%-1.02M | 153.11%204.31K | -54.24%432.72K | -60.85%2.84M | 250.29%1.65M | 14.25%627.38K | -124.45%-384.68K | -84.84%945.61K |
| -Change in payables and accrued expense | -594.48%-1.9M | -41.56%2.2M | 36.41%-1.45M | -566.78%-2.82M | 107.04%167.03K | -107.29%-274.08K | 292.81%3.77M | 49.28%-2.28M | -93.86%605.21K | -780.42%-2.37M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -0.19%-51.76M | 14.15%-8.8M | -43.21%-16.66M | 0.08%-13.26M | 21.01%-13.04M | 50.23%-51.66M | 71.44%-10.25M | 56.70%-11.63M | 38.62%-13.27M | 15.05%-16.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 2.20%51.56M | 46.56%11.35M | 318.19%16.14M | 1,316.79%14.01M | -74.86%10.06M | 155.67%50.45M | 567.62%7.74M | -87.77%3.86M | -719.62%-1.15M | 498.93%40M |
| Net investment purchase and sale | 2.20%51.56M | 46.56%11.35M | 318.19%16.14M | 1,316.79%14.01M | -74.86%10.06M | 155.67%50.45M | 567.62%7.74M | -87.77%3.86M | -719.62%-1.15M | 498.93%40M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 2.20%51.56M | 46.56%11.35M | 318.19%16.14M | 1,316.79%14.01M | -74.86%10.06M | 155.67%50.45M | 567.62%7.74M | -87.77%3.86M | -719.62%-1.15M | 498.93%40M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 59.03%-40.34K | -75.18%-172.49K | -89.6K | 0 | 221.75K | -100.22%-98.46K | -124.02%-98.46K | 0 | 0 | 0 |
| Net common stock issuance | --246.75K | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | --246.75K | ---- | ---- | ---- | ---- | --0 |
| Net other financing activities | -191.57%-287.09K | ---172.49K | ---89.6K | --0 | ---25K | -130.42%-98.46K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 59.03%-40.34K | -75.18%-172.49K | ---89.6K | --0 | --221.75K | -100.22%-98.46K | -124.02%-98.46K | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -24.17%4.09M | -77.85%1.48M | -85.58%2.09M | -95.38%1.34M | -24.17%4.09M | -87.86%5.4M | -84.25%6.7M | -61.17%14.47M | -35.70%28.89M | -87.86%5.4M |
| Current changes in cash | 82.02%-234.54K | 191.03%2.37M | 92.25%-602.47K | 105.21%751.24K | -111.73%-2.76M | 96.66%-1.3M | 92.98%-2.61M | -247.63%-7.77M | -87.98%-14.43M | 4,686.45%23.5M |
| End cash Position | -5.73%3.86M | -5.73%3.86M | -77.85%1.48M | -85.58%2.09M | -95.38%1.34M | -24.17%4.09M | -24.17%4.09M | -84.25%6.7M | -61.17%14.47M | -35.70%28.89M |
| Free cash flow | -0.19%-51.76M | 14.15%-8.8M | -43.21%-16.66M | 0.08%-13.26M | 21.01%-13.04M | 50.23%-51.66M | 71.44%-10.25M | 56.70%-11.63M | 38.62%-13.27M | 15.05%-16.51M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call